Discussion on: Routine Diagnostic Immunophenotypic Profiling in AML Identifies Chemo Resistant Patients and Predicts Treatment Outcomes

Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.

Article Title

Routine Diagnostic Immunophenotypic Profiling in AML Identifies Chemo Resistant Patients and Predicts Treatment Outcomes

Authored by

Birva Raiya
Immunohematology Lab, The Gujarat Cancer and Research Institute, Ahmedabad, India.

Shana Laliwala
Immunohematology Lab, The Gujarat Cancer and Research Institute, Ahmedabad, India.

Jayendra Patel
Molecular Diagnostic and Research Lab 2, The Gujarat Cancer and Research Institute, Ahmedabad, India.

Pina Trivedi
Cytogenetic Lab, The Gujarat Cancer and Research Institute, Ahmedabad, India.

Hemangini Vora
Immunohematology Lab, The Gujarat Cancer and Research Institute, Ahmedabad, India.

DOI or Article Link

https://journalahrj.com/index.php/AHRJ/article/view/180

Leave a Comment